Your browser doesn't support javascript.
loading
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol, C; Albasanz-Puig, A; Laporte-Amargós, J; Pallarès, N; Mussetti, A; Ruiz-Camps, I; Puerta-Alcalde, P; Abdala, E; Oltolini, C; Akova, M; Montejo, M; Mikulska, M; Martín-Dávila, P; Herrera, F; Gasch, O; Drgona, L; Paz Morales, H; Brunel, A-S; García, E; Isler, B; Kern, W V; Morales, I; Maestro-de la Calle, G; Montero, M; Kanj, S S; Sipahi, O R; Calik, S; Márquez-Gómez, I; Marin, J I; Gomes, M Z R; Hemmatti, P; Araos, R; Peghin, M; Del Pozo, J L; Yáñez, L; Tilley, R; Manzur, A; Novo, A; Carratalà, J.
Afiliación
  • Gudiol C; Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain cgudiol@iconcologia.net jcarratala@bellvitgehospital.cat.
  • Albasanz-Puig A; Institut Català d'Oncologia (ICO)-Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
  • Laporte-Amargós J; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Pallarès N; Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain.
  • Mussetti A; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Ruiz-Camps I; Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain.
  • Puerta-Alcalde P; Statistics Advisory Service, Institute of Biomedical Research of Bellvitge, Barcelona, Spain.
  • Abdala E; Haematology Department, Institut Català d'Oncologia (ICO)-Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
  • Oltolini C; Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Akova M; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Montejo M; Infectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
  • Mikulska M; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Martín-Dávila P; Instituto do Câncer do Estado de São Paulo, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Herrera F; Unit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Gasch O; Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey.
  • Drgona L; Infectious Diseases Unit, Cruces University Hospital, Bilbao, Spain.
  • Paz Morales H; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Brunel AS; Division of Infectious Diseases, University of Genoa (DISSAL) and Ospedale Policlinico San Martino, Genoa, Italy.
  • García E; Infectious Diseases Department, Ramon y Cajal Hospital, Madrid, Spain.
  • Isler B; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Kern WV; Infectious Diseases Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina.
  • Morales I; Infectious Diseases Department, Parc Taulí University Hospital, Sabadell, Spain.
  • Maestro-de la Calle G; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Montero M; Oncohematology Department, Comenius University and National Cancer Institute, Bratislava, Slovakia.
  • Kanj SS; Infectious Diseases Department, Hospital Erasto Gaertner, Curitiba, Brazil.
  • Sipahi OR; Infectious Diseases Department, Department of Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Calik S; Haematology Department, Reina Sofía University Hospital-IMIBIC-UCO, Córdoba, Spain.
  • Márquez-Gómez I; Department of Infectious Diseases and Clinical Microbiology, Istanbul Education and Research Hospital, Istanbul, Turkey.
  • Marin JI; Division of Infectious Diseases, Department of Medicine II, University of Freiburg Medical Center and Faculty of Medicine, Freiburg, Germany.
  • Gomes MZR; Emergency Clinical Unit and Infectious Diseases Division, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Hemmatti P; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Araos R; Infectious Diseases Unit, Instituto de Investigación Hospital 12 de Octubre (i+12), 12 de Octubre University Hospital, School of Medicine, Universidad Complutense, Madrid, Spain.
  • Peghin M; Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigations Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain.
  • Del Pozo JL; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), Instituto de Salud Carlos III, Madrid, Spain.
  • Yáñez L; Infectious Diseases Division, American University of Beirut Medical Center, Beirut, Lebanon.
  • Tilley R; Ege University Faculty of Medicine, Izmir, Turkey.
  • Manzur A; University of Health Science Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
  • Novo A; Infectious Diseases Department, Hospital Regional de Málaga, Málaga, Spain.
  • Carratalà J; Infectious Diseases and Clinical Microbiology Department, Clínica Maraya, Pereira, Colombia.
Antimicrob Agents Chemother ; 64(4)2020 03 24.
Article en En | MEDLINE | ID: mdl-32015035
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por Pseudomonas / Bacteriemia / Farmacorresistencia Bacteriana Múltiple / Neoplasias / Neutropenia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por Pseudomonas / Bacteriemia / Farmacorresistencia Bacteriana Múltiple / Neoplasias / Neutropenia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article